Cargando…
immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy
Protein-based therapeutics can activate the adaptive immune system and lead to the production of neutralizing antibodies and to cytotoxic-T-cell-mediated clearance of the treated cells. Here, we show that the sequential use of immune-orthogonal orthologues of the CRISPR-associated protein 9 (Cas9) a...
Autores principales: | Moreno, Ana M., Palmer, Nathan, Alemán, Fernando, Chen, Genghao, Pla, Andrew, Jiang, Ning, Chew, Wei Leong, Law, Mansun, Mali, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783354/ https://www.ncbi.nlm.nih.gov/pubmed/31332341 http://dx.doi.org/10.1038/s41551-019-0431-2 |
Ejemplares similares
-
Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing
por: Esvelt, Kevin M., et al.
Publicado: (2013) -
Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
por: Bartel, Melissa, et al.
Publicado: (2011) -
How Dengue Virus Circumvents Innate Immunity
por: Kao, Yu-Ting, et al.
Publicado: (2018) -
Antibodies against viruses: passive and active immunization
por: Law, Mansun, et al.
Publicado: (2008) -
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)